Product
KH631
2 clinical trials
1 indication
Indication
Age-related macular degenerationClinical trial
A Phase I, Open-label, Multicenter, Dose-Escalating Study to Evaluate the Safety and Tolerability of KH631 Gene Therapy in Participants With Neovascular Age-related Macular DegenerationStatus: Recruiting, Estimated PCD: 2026-09-01
Clinical trial
A Phase I/II, Open-label, Multiple-cohort, Dose-escalation Study to Evaluate the Safety and Tolerability of KH631 Gene Therapy in Subjects With Neovascular Age-related Macular Degeneration (nAMD)Status: Recruiting, Estimated PCD: 2026-12-28